Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Medicines Adaptive Pathways to Patients (MAPPs) seeks to foster access to novel beneficial treatments for the right patient groups at the earliest appropriate time in the product life‐span, in a sustainable fashion. We summarize the MAPPs engagement process and critical questions to be asked at each...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, Hans‐Georg, Bedlington, Nicola, Boudes, Mathieu, Bouvy, Jacoline C., Broekmans, André W., Cerreta, Francesca, Faulkner, Stuart D., Forda, Susan R., Joos, Angelika, Le Cam, Yann, Mayer, Mark H., Pirard, Vinciane, Corriol‐Rohou, Solange
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585618/
https://www.ncbi.nlm.nih.gov/pubmed/29901216
http://dx.doi.org/10.1002/cpt.1121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585618/
https://www.ncbi.nlm.nih.gov/pubmed/29901216
http://dx.doi.org/10.1002/cpt.1121

Ejemplares similares